Pivotal bioVenture Partners Fund I, L.P.
Director, 10% Owner
Fund
- 2025
- Nov 12, 2025
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Pivotal bioVenture Partners Fund I, L.P. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- 7. Cooperative Ua Lsp - $25.00M in EVMN purchases and sales in the last 12 months
- Weegen Felice Isabel Verduyn-Van - $25.00M in EVMN purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $20.00M in EVMN purchases and sales in the last 12 months
- Luis C. Pena - $551K in EVMN purchases and sales in the last 12 months
- Janice Suzann Drew - $453K in EVMN purchases and sales in the last 12 months
- Kyle Carver - $428K in EVMN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is Pivotal bioVenture Partners Fund I, L.P.?
Pivotal bioVenture Partners Fund I, L.P. is an investment firm, tracked as Director, 10% Owner of Evommune, Inc. (EVMN). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Pivotal bioVenture Partners Fund I, L.P. last file a Form 4?
The only primary Form 4 on record is dated 12 November 2025.
